AB050. SHR-1316 plus nab-paclitaxel and carboplatin as the first line therapy for advanced, unresectable, recurrent or metastatic thymic carcinoma
@article{Mediastinum9610, author = {Ning Xu and Wentao Fang}, title = {AB050. SHR-1316 plus nab-paclitaxel and carboplatin as the first line therapy for advanced, unresectable, recurrent or metastatic thymic carcinoma}, journal = {Mediastinum}, volume = {8}, number = {0}, year = {2024}, keywords = {}, abstract = {}, issn = {2522-6711}, url = {https://med.amegroups.org/article/view/9610} }